Paper Titles in Periodical
International Journal of Pharmacology, Phytochemistry and Ethnomedicine
IJPPE Volume 1
Subscribe

Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

IJPPE > IJPPE Volume 1 > Nebivaolol Effect in Patients with Chronic...
Nebivaolol Effect in Patients with Chronic Obstructive Disease of the Lungs
< Back to Volume

Nebivaolol Effect in Patients with Chronic Obstructive Disease of the Lungs

Full Text PDF

Abstract:

Introduction: Chronic obstructive disease of the lungs (CODL) is one of the leading cases of morbidity and mortality all over the world. It is one of the causes which may form the basis of sudden death, it serves as disturbance of cardiac contractions rhythm. Aim of the research is to evaluate the effect of adrenoreceptor – nebivaolol by selective blocker β1 on pulmonary hypertension degree in patients with chronic obstructive disease of the lungs. Material and methods: 60 patients with chronic obstructive disease of the lungs of III-IV stage in exacerbation phase were enrolled in the study. The patients were subdivided into 2 groups: group A for comparison (n-25) and group B for study (n=35). The patients of both groups received standard therapy, directed to elimination of inflammatory process and improvement of bronchial permeability: antibiotics, broncholytics, mucolytics. The patients of group B were treated with nebivaolol in the dosage 10 mg 24 hours (5 mg dose 2 times 24 hours) for 14 days. Results: In absence of negative effect on hemodynamic indexes, electrophysiological parameters and sporometric data reveal changes in the rate of cardiac contractions to adequate values and significant increase of tolerance to physical exertion in 2 weeks after taking nebivaolol. Decrease of heart rate correlates with decrease of pulmonary hypertension. Conclusion: Taking into account the received findings nebivaolol can be recommended for treatment of patients with chronic obstructive disease of the lungs and pulmonary hypertension.

Info:

Periodical:
International Journal of Pharmacology, Phytochemistry and Ethnomedicine (Volume 1)
Pages:
74-80
DOI:
https://doi.org/10.18052/www.scipress.com/IJPPE.1.74
Citation:
G.A. Holov et al., "Nebivaolol Effect in Patients with Chronic Obstructive Disease of the Lungs", International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Vol. 1, pp. 74-80, 2015
Online since:
December 2015
Authors:
G.A. Holov, S.I. Abdijalilova, U.Sh. Ganiev, Sh.N. Salohidinov, B.M. Shakirov
Keywords:
Chronic Obstructive Disease of Lungs, Nebivaolol, Treatment
Export:
RIS, BibTeX, Text
Distribution:
Open Access

Creative Commons License
This work is licensed under a
Creative Commons Attribution 4.0 International License

References:

Adamyan K.G., Chilingaryan A.L. Comparative effectiveness of ivabradine and verapamil in patients with diastolic cardiac insufficiency due to impaired relaxation of the left ventricle. Rational Pharmacotherapy in cardiology; 2009: 3: 31-35.

Singch B.N. Impact of reduced heart rate. Morbidity in cardiovascular disorders. J. Cardiovasc Pharmacol Ther. 2001; 6: 313-31.

Reil J.C., Bohm M. Beautiful results the slower, the better? Lancet 2008; 372: 779-80.

Fox K., Ford I., Steg P.G., Tendera M, Robertson M., Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (Beautiful): a subgroup analysis of a randomized controlled trial. Lancet 2008; 372: 817-821.

Salpeter S.R., Ormiston T.M., Salpeter E.E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125: 21-3.

Thollon C., Cambarrat C., Vian J., Prost J.F., Peglion J.L., Vilaine J.P. Electrophysiological effects of 16257, a novel sino-atrial node modulator, in rabbit and guinea- pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol 1994; 112: 37-42.

Fomin I.V., Valiculova F. Yu. Antianginal effect of long use of avabradine in patients with ischemic heart disease and diabetes mellitus. Journal Cardiology 2009; 3: 9-5.

Komlev A.D., Volkova A.L., Arutunov V.A. Influence of canals blocker Ifivabrodine on the indexes of external breathing functions in patients with chronic obstructive disease of the lungs in the period of stable course of the disease. Ter. Arch. 2010; 3: 23-7.

Abdurarachmanova G.M., Zulkarneev R.H., Zagudulin N.S. Effect of Ifvabradine and salbutamol combination on heart rate frequency and external breathing function in patients with chronic obstructive disease of the lungs in combination with IHD. Collection of thesis of ХХ congress on respiratory organs disease; 10-11.

Show More Hide
Cited By:
This article has no citations.